Yahoo Web Search

Search results

1. ADMA Biologics, Inc.

   NasdaqGM: ADMA

   8.81

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +1.88 (+27.13%)

   At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	8.20
     High	9.02
     Low	7.96

   • Mkt Cap	2.04B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	6.93
     52 Wk. Low	3.06
     52 Wk. High	9.02

   More about ADMA

   Top stories

   • ADMA
     +27.13%

   ADMA Biologics First Quarter 2024 Earnings: Beats Expectations

   Yahoo Finance · 24 hours ago

   

   • OVID
     -1.64%
   • ADMA
     +27.13%

   Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates

   Yahoo Finance · 3 days ago

   

   • ADMA
     +27.13%

   ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript

   Yahoo Finance · 2 days ago

   

   Related stocks

   • VBIV
     VBI Vaccines Inc.
     VBIV
     0.6200
     +2.77%
   • SONN
     Sonnet BioTherapeutics Holdings, Inc.
     SONN
     1.7000
     -7.10%
   • ABUS
     Arbutus Biopharma Corporation
     ABUS
     2.8800
     -2.04%
   • ALDX
     Aldeyra Therapeutics, Inc.
     ALDX
     3.7700
     -4.31%
   • XERS
     Xeris Biopharma Holdings, Inc.
     XERS
     1.7600
     -6.38%

   More on Yahoo Finance

2. finance.yahoo.com › quote › ADMAADMA Biologics, Inc. (ADMA) Stock Price, News, Quote ...

   finance.yahoo.com › quote › ADMA

   • Cached

   ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious...

3. finance.yahoo.com › news › adma-biologics-inc-admaADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and ...

   finance.yahoo.com › news › adma-biologics-inc-adma

   • Cached

   2 days ago · ADMA's gross profit for the quarter stood at $39.1 million with a corporate gross margin of 48%, compared to $16.5 million and a 29% margin in the first quarter of 2023.

4. www.google.com › finance › quoteADMA Biologics Inc (ADMA) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest ADMA Biologics Inc (ADMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5. People also ask

   Who is ADMA biologics?

   • Pre. Pre. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

   ADMA Biologics, Inc. (ADMA) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/ADMA

   See all results for this question

   Is ADMA biologics (ADMA) a good stock to buy?

   • ADMA Biologics (NASDAQ: ADMA) just reported results for the first quarter of 2024. ADMA Biologics reported earnings per share of 8 cents. This was above the analyst estimate for EPS of 5 cents. The company reported revenue of $81.88 million. This was 5.96% better than the analyst estimate for revenue of $77.27 million.

   ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q…

   markets.businessinsider.com/news/stocks/adma-stock-earnings-adma-biologics-for-q1-of-2024-1033358954

   See all results for this question

   What is ADMA ri 002?

   • Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey. View ADMA Biologics Inc ADMA investment & stock information.

   ADMA Biologics - ADMA - Stock Price Today - Zacks

   www.zacks.com/stock/quote/ADMA

   See all results for this question

   Does ADMA biopharmaceutical work?

   • The Only Hitch: It Might Not Work. ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate.

   ADMA Stock Price | ADMA Biologics Inc. Stock Quote (U.S.: Nasdaq

   www.marketwatch.com/investing/stock/adma

   See all results for this question

6. markets.businessinsider.com › news › stocksADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue ...

   markets.businessinsider.com › news › stocks

   • Cached

   2 days ago · ADMA Biologics reported earnings per share of 8 cents. This was above the analyst estimate for EPS of 5 cents. The company reported revenue of $81.88 million. This was 5.96% better than the ...

7. www.marketwatch.com › investing › stockADMA Stock Price | ADMA Biologics Inc. Stock Quote (U.S ...

   www.marketwatch.com › investing › stock

   3 days ago · ADMA is a biotechnology company that develops and commercializes plasma-derived biologics for immunodeficiency and infectious diseases. Get the latest stock price, earnings, analyst ratings, news and more for ADMA on MarketWatch.

8. www.zacks.com › stock › quoteADMA Biologics - ADMA - Stock Price Today - Zacks

   www.zacks.com › stock › quote

   • Cached

   4 days ago · ADMA Biologics (ADMA) (Delayed Data from NSDQ) $8.81 USD. +1.88 (27.13%) Updated May 10, 2024 04:00 PM ET. After-Market: $8.81 0.00 (0.00%) 7:58 PM ET. Add to portfolio. Zacks Rank: 1-Strong...

9. seekingalpha.com › symbol › ADMAADMA Biologics, Inc. (ADMA) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › ADMA

   • Cached

   May 2, 2024 · A high-level overview of ADMA Biologics, Inc. (ADMA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.